艾伯維藥品 ABBV
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q1 | 209.52 | 163.16 | 88.17 | 0.72 | 3,733,000 | 1,286 |
| 2024Q4 | 177.70 | 89.81 | 73.40 | -0.02 | -1,490,000 | -22 |
| 2024Q3 | 197.48 | 143.21 | 68.10 | 0.88 | 3,831,000 | 1,561 |
| 2024Q2 | 171.52 | 150.75 | 50.54 | 0.76 | 3,998,000 | 1,370 |
| 2024Q1 | 182.10 | 126.72 | 66.15 | 0.77 | 2,798,000 | 1,369 |
| 2023Q4 | 154.97 | 200.94 | 42.00 | 0.46 | 3,195,000 | 822 |
| 2023Q3 | 149.06 | 97.02 | 30.29 | 1.00 | 2,281,000 | 1,778 |
| 2023Q2 | 134.73 | 147.29 | 27.37 | 1.13 | 4,513,000 | 2,024 |
| 2023Q1 | 159.37 | 297.95 | 23.85 | 0.13 | 2,768,000 | 239 |
| 2022Q4 | 161.61 | 159.90 | 21.32 | 1.39 | 5,502,000 | 2,473 |
| 2022Q3 | 134.21 | 94.00 | 18.78 | 2.21 | 4,603,000 | 3,949 |
| 2022Q2 | 153.16 | 192.13 | 21.69 | 0.52 | 3,295,000 | 924 |
| 2022Q1 | 162.11 | 86.27 | 24.81 | 2.51 | 4,717,000 | 4,490 |
| 2021Q4 | 135.40 | 104.79 | 31.77 | 2.26 | 5,074,000 | 4,044 |
| 2021Q3 | 107.87 | 100.77 | 28.61 | 1.78 | 4,306,000 | 3,179 |
| 2021Q2 | 112.64 | 251.05 | 38.56 | 0.42 | 4,441,000 | 766 |
| 2021Q1 | 108.22 | 91.40 | 41.38 | 1.99 | 4,103,000 | 3,553 |
| 2020Q4 | 107.15 | -422.16 | 25.63 | -0.05 | 3,753,000 | 36 |
| 2020Q3 | 87.59 | 104.33 | 22.22 | 1.34 | 3,255,000 | 2,308 |
| 2020Q2 | 98.18 | -951.90 | 20.51 | -0.59 | 752,000 | -738 |